Differential Effects of Nicotine and Aging on Splenocyte Proliferation and the Production of Th1- Versus Th2-Type Cytokines
- 1 July 2000
- journal article
- Published by Wiley in Proceedings of the Society for Experimental Biology and Medicine
- Vol. 224 (3) , 141-146
- https://doi.org/10.1046/j.1525-1373.2000.22412.x
Abstract
Nicotine has a multitude of biological actions in the central and peripheral nervous systems where nicotinic acetylcholine receptors are found. Nicotinic acetylcholine receptors have also been identified on immune cells, but the effects of nicotine on immune responses are not well characterized. These studies tested the hypotheses that nicotine has an effect on both T-lymphocyte proliferation and the production of cytokines by activated T cells, processes that are necessary for effective T-cell-mediated immune responses. In addition, the effects of nicotine on these immune responses in aging animals and the effects of nicotine exposure prior to immunostimulation were investigated. Murine splenocytes were exposed to nicotine and stimulated with concanavalin A (ConA). The highest concentration of nicotine (128 microg/ml) significantly depressed proliferation of T cells both when nicotine and ConA were added concurrently and when nicotine was added 3 hr prior to ConA. Nicotine, added concurrently with ConA at concentrations between 0. 25 and 64 microg/ml, significantly inhibited the production of IL-10 by splenocytes from young adult mice, whereas the inhibition of production of IL-10 by splenocytes from old mice was significantly inhibited, but the response was more variable, depending on the nicotine concentration. In contrast, the production of IFN-gamma by splenocytes from either young adult or old mice was not affected when nicotine (0.016-64 microg/ml) was added concurrently with ConA. Pre-exposure to 1 microg/ml of nicotine for 3 hr significantly enhanced the production of IFN-gamma by splenocytes from young adult mice, whereas pre-exposure to 0.016 microg/ml of nicotine tended to but did not significantly enhance IFN-gamma production. Nicotine is now being used as an over-the-counter drug by people who differ in age and general immunocompetence. Therefore, the effects of nicotine on immune responses, independent from the effects of the other chemicals found in tobacco, need to be investigated.Keywords
This publication has 36 references indexed in Scilit:
- TOBACCO AND LUNG CANCERPrimary Care: Clinics in Office Practice, 1998
- Identification of Tobacco- Specific Carcinogen in the Cervical Mucus of Smokers and NonsmokersJNCI Journal of the National Cancer Institute, 1997
- Age-Related Changes of Cytokine Production by Murine Helper T Cell SubpopulationsPathobiology, 1997
- Beneficial effects of nicotine and cigarette smoking: the real, the possible and the spuriousBritish Medical Bulletin, 1996
- Pharmacology of Nicotine: Addiction and TherapeuticsAnnual Review of Pharmacology and Toxicology, 1996
- Effects of Nicotine on the Immune Response. I. Chronic Exposure to Nicotine Impairs Antigen Receptor-Mediated Signal Transduction in LymphocytesToxicology and Applied Pharmacology, 1995
- Effect of Age on Blood Pressure Response to Cigarette SmokingCardiology, 1995
- Simultaneous determination of nicotine and cotinine in various human tissues using capillary gas chromatography/mass spectrometryInternational journal of legal medicine, 1994
- Polymorphism of age‐related changes in interleukin (IL) production: differential changes of T helper subpopulations, synthesizing IL 2, IL3 and IL4European Journal of Immunology, 1990
- Oral administration of nicotine: Its uptake and distribution after chronic administration to miceJournal of Pharmacological Methods, 1983